Clinical trial of genetically modified Lactobacillus brevis for treatment of inflammatory bowel disease
Commercial supply of Qdenga, a live attenuated GM dengue vaccine
This is a hypothetical case study provided as an example. It should not be cited as evidence in an application. Although the data and discussions are representative, this example may not include all considerations needed when assessing risks from a proposed GM plant limited and controlled release.
Commercial release of canola genetically modified for herbicide tolerance and a hybrid breeding system (MS11× RF3 and MS11 × RF3 × MON 88302)
This Communiqué covers matters considered at the 33rd videoconference of the Gene Technology Technical Advisory Committee (15 May 2023).
This document provides answers to frequently asked questions relating to the OGTR's Online Services Portal (Portal).
This document provides step by step instructions on how to register for the OGTR's Online Services Portal.
This guide provides assistance from the point of logging into the OGTR Online Services Portal. It follows from the OGTR Online Services Registration Guide.
This document provides a step by step guide on how to access the NLRD Form in the OGTR's Online Services Portal.
Clinical trial of a genetically modified alphavirus (Getah virus) for cancer treatment